RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 31 Oct 2024
Last Applicant/ Owned by
Ste 102, National Innovation Centre
Eveleigh, NSW
AU
2015
Serial Number
98326981 filed on 21st Dec 2023
Registration Number
N/A
Correspondent Address
Sydney R. Jensen
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
STIPLEX
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health care services specifically dna, genetics and genetic testing for medical purposes; medical diagnostic services in the nature of medical testing and medical analysis services for diagnostic purposes provided by medical laboratories; medical diagnostic imaging and molecular medicine being medical services; molecular medical diagnostics testing;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; product development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services to diagnose and identify pathogens, infections, and infectious diseases for medical or scientific research purposes; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services for scientific purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom in the nature of genetic testing for scientific research purposes; scientific research namely provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; custom design and development of biochemical assays;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [010]
Medical Instrument Products
Surgical apparatus and instruments; medical instrument for diagnostic use, namely, apparatus for medical diagnostic testing to diagnose and identify pathogens, infections, and infectious diseases, or other tissue-based diagnostic testing, cytology and cell-based testing specifically for the purposes of analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical diagnostic apparatus for diagnosis and identification of, infections, and infectious diseases; diagnostic testing kits consisting primarily of medical apparatus and instruments for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological chemical test kits containing diagnostic preparations for medical purposes used in medical laboratories in the nature of nucleic acid substrates used for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules being diagnostic reagents and preparations, except for medical or veterinary use for the purpose of detection and identification of pathogens, for the detection of antibiotic resistance, and medical diagnostic reagents for the analysis of body fluids specifically for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, and for analysis of response to therapy and preparations for detecting and preparations for analysis of gene expression specifically for medical or medical research purposes; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing preparations being nucleic acid sequences for medical use; chemical preparations containing enzymes for medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes specifically for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical kits containing medical diagnostic reagents for testing and analysis of bodily fluids for use in disease detection and/or analysis of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping; diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits in the nature of medical diagnostic reagents and assays for testing body fluids for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents for scientific or medical research use; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acid for other than medical and veterinary purposes; acids namely inorganic acids for industrial purposes; DNA polymerase for scientific purposes; chemicals used in environmental monitoring in the nature of chemical preparations for scientific purposes, other than for medical or veterinary use;
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98326981
Mark Type
No Service Mark
Attorney Docket Number
No T-5040 US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Oct 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Oct 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Oct 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 30th Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 30th Jul 2024 | NON-FINAL ACTION E-MAILED |
| 30th Jul 2024 | NON-FINAL ACTION WRITTEN |
| 22nd Jul 2024 | ASSIGNED TO EXAMINER |
| 08th Apr 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 21st Dec 2023 | NEW APPLICATION ENTERED |